Orchid Pharma rallied 3.92% to Rs 1,037.50 after the company said that it has received an approval from Drugs Controller General of India (DCGI) to manufacture and market its new chemical entity active pharmaceutical ingredient (API), Enmetazobactam.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.